Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lerner

Showing results (221-230 of 299) with videos related to

Pageof 30
Sort By:
Scandinavian Journal of Infectious Diseases|January 1, 1992
Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle SwedenJ Samuelsson, B Lönnqvist, J Palmblad, et al.
Menopause (New York, N.Y.)|April 11, 2013
Flaxseed reverses atherosclerotic lesion formation and lowers lipoprotein(a) in ovarian hormone deficiencySara C Campbell, Neema Bakhshalian, Raz L Sadaat, et al.
Regulatory Peptides|March 1, 1989
Respiratory and cardiovascular effects of thyrotropin-releasing hormone as modified by isoflurane, enflurane, pentobarbital and ketamineC F Schaefer, D J Brackett, B Biber, et al.
FEBS Letters|April 21, 1986
Peptides of postulated inhibin activity. Lack of in vitro inhibin activity of a 94-residue peptide isolated from human seminal plasma, and of a synthetic replicate of its C-terminal 28-residue segmentS Kohan, B Fröysa, E Cederlund, et al.
Anticancer Research|January 1, 2015
Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft modelJason W Kesinger, Meghna Mehta, Megan R Lerner, et al.
Cancer|August 27, 1999
Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagusJ S Hanas, M R Lerner, S A Lightfoot, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 18, 2003
DNA ploidy and markovian analysis of neoplastic progression in experimental pancreatic cancerRussell G Postier, Megan R Lerner, Stan A Lightfoot, et al.
The Journal of Clinical Investigation|July 1, 1982
Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particlesJ A Hardin, D R Rahn, C Shen, et al.
Free Radical Biology & Medicine|April 1, 1993
Evidence that the large loss of glutathione observed in ischemia/reperfusion of the small intestine is not due to oxidation to glutathione disulfideD D Gibson, D J Brackett, R A Squires, et al.
Journal of Internal Medicine|April 1, 1992
Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemiasJ Palmblad, B Lönnqvist, B Carlsson, et al.
Pageof 30

Showing results (221-230 of 299) with videos related to

Sort By:
Pageof 30
Scandinavian Journal of Infectious Diseases|January 1, 1992
Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle SwedenJ Samuelsson, B Lönnqvist, J Palmblad, et al.
Menopause (New York, N.Y.)|April 11, 2013
Flaxseed reverses atherosclerotic lesion formation and lowers lipoprotein(a) in ovarian hormone deficiencySara C Campbell, Neema Bakhshalian, Raz L Sadaat, et al.
Regulatory Peptides|March 1, 1989
Respiratory and cardiovascular effects of thyrotropin-releasing hormone as modified by isoflurane, enflurane, pentobarbital and ketamineC F Schaefer, D J Brackett, B Biber, et al.
FEBS Letters|April 21, 1986
Peptides of postulated inhibin activity. Lack of in vitro inhibin activity of a 94-residue peptide isolated from human seminal plasma, and of a synthetic replicate of its C-terminal 28-residue segmentS Kohan, B Fröysa, E Cederlund, et al.
Anticancer Research|January 1, 2015
Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft modelJason W Kesinger, Meghna Mehta, Megan R Lerner, et al.
Cancer|August 27, 1999
Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagusJ S Hanas, M R Lerner, S A Lightfoot, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 18, 2003
DNA ploidy and markovian analysis of neoplastic progression in experimental pancreatic cancerRussell G Postier, Megan R Lerner, Stan A Lightfoot, et al.
The Journal of Clinical Investigation|July 1, 1982
Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particlesJ A Hardin, D R Rahn, C Shen, et al.
Free Radical Biology & Medicine|April 1, 1993
Evidence that the large loss of glutathione observed in ischemia/reperfusion of the small intestine is not due to oxidation to glutathione disulfideD D Gibson, D J Brackett, R A Squires, et al.
Journal of Internal Medicine|April 1, 1992
Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemiasJ Palmblad, B Lönnqvist, B Carlsson, et al.
Pageof 30